India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Divi’s Lab.
Read More
February 8, 2026
- TISHHA Organises CPR Training Programme for NGO Staff in Bareilly
- Medanta Q3 Net Profit Falls 34% to Rs 95 Crore Despite Revenue Growth
- SC Seeks Centre’s Explanation on Lowering NEET-PG Cut-off, Raises Concerns Over Standards
- Delhi HC Strikes Down NMC Rule Imposing Blanket Ban on MBBS Student Migration